SCHEMBL14907667

SCHEMBL14907667

COC(=O)Nc1ccccc1CNC(=S)NCc1ccnc2[nH]ccc12

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NUDT1 P36639 2/20 0.39
JAK2 O60674 1/20 0.37
JAK1 P23458 1/20 0.37
TYK2 P29597 1/20 0.37
ALDH1A1 P00352 3/20 0.37
LMNA P02545 2/20 0.37
HPGD P15428 1/20 0.37
ALOX15 P16050 1/20 0.37
HSD17B10 Q99714 1/20 0.37
ROCK2 O75116 3/20 0.37
CIT O14578 2/20 0.37
PRKD3 O94806 1/20 0.37
MAP4K4 O95819 1/20 0.37
PRKCB P05771 1/20 0.37
PRKCA P17252 1/20 0.37
PRKACA P17612 1/20 0.37
CSNK2A2 P19784 1/20 0.37
MARK3 P27448 1/20 0.37
BMPR1A P36894 1/20 0.37
CSNK1A1 P48729 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14894259 0.89 BTK (0.40) NUDT1JAK2JAK1TYK2ALDH1A1
SCHEMBL14894074 0.89 TSHR (0.41) NUDT1JAK2JAK1TYK2ALDH1A1
SCHEMBL14893875 0.88 JAK2 (0.39) NUDT1JAK2JAK1TYK2ALDH1A1
SCHEMBL14907957 0.88 NUDT1 (0.39) NUDT1JAK2JAK1TYK2ALDH1A1
SCHEMBL14894091 0.86 CIT (0.38) NUDT1JAK2JAK1TYK2ALDH1A1
SCHEMBL14894279 0.85 NUDT1 (0.38) NUDT1JAK2JAK1TYK2ALDH1A1
SCHEMBL14907815 0.85 SMN1; SMN2 (0.43) NUDT1JAK2JAK1TYK2ALDH1A1
SCHEMBL14894275 0.84 PTPN1 (0.42) NUDT1JAK2JAK1TYK2ROCK1
SCHEMBL14907987 0.84 ALDH1A1 (0.37) NUDT1JAK2JAK1TYK2ALDH1A1
SCHEMBL16107726 0.79 CIT (0.39) NUDT1JAK2JAK1CITPRKD3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9174984-B2 Chemical compounds GLAXOSMITHKLINE INTELLECTUAL PROPERTY (NO.2) LIMITED (GB) 2015-11-03 US disclosed
US-20140296204-A1 CHEMICAL COMPOUNDS GLAXOSMITHKLINE INTELLECTUAL PROPERTY (NO.2) LIMITED (GB) 2014-10-02 US disclosed
WO-2013062945-A1 CHEMICAL COMPOUNDS GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED (GB) 2013-05-02 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140296204-A1 CHEMICAL COMPOUNDS DNMT1, DNMT3A, DNMT3B NUDT1 829/4885JAK2 381/4885JAK1 1077/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.